US Stock MarketDetailed Quotes

Neuphoria Therapeutics (NEUP)

Watchlist
  • 4.720
  • +0.070+1.51%
Close Apr 16 16:00 ET
  • 4.720
  • 0.0000.00%
Post 16:10 ET
25.45MMarket Cap2.78P/E (TTM)

Neuphoria Therapeutics (NEUP) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Dec 31, 2025
(Q1)Sep 30, 2025
(FY)Jun 30, 2025
(Q4)Jun 30, 2025
(Q3)Mar 31, 2025
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
Total revenue
0
0
15.65M
-13.27K
15M
662.72K
0
0
0
0
Operating revenue
--0
--0
--15.65M
---13.27K
--15M
--662.72K
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-42.22%2.35M
58.44%5.65M
-7.41%16.48M
6.30%5.82M
26.50%3.03M
-8.93%4.06M
-34.75%3.57M
-17.45%17.8M
5.48M
2.39M
Selling and administrative expenses
-19.10%2.13M
12.01%1.87M
-8.27%7.77M
-13.06%2.07M
17.68%1.41M
4.42%2.63M
-29.95%1.67M
-4.90%8.47M
--2.38M
--1.2M
-General and administrative expense
-19.10%2.13M
12.01%1.87M
-8.27%7.77M
-13.06%2.07M
17.68%1.41M
4.42%2.63M
-29.95%1.67M
-4.90%8.47M
--2.38M
--1.2M
Research and development costs
-59.83%697.72K
99.15%3.79M
-4.38%9.01M
21.16%3.75M
34.83%1.62M
-14.64%1.74M
-38.45%1.9M
-27.95%9.42M
--3.1M
--1.2M
Other operating expenses
-56.40%-478.96K
----
-214.98%-299.91K
570.51%1.1K
2,028.78%5.23K
-223.34%-306.23K
----
77.48%-95.22K
---234
---271
Operating profit
30.95%-2.35M
-58.44%-5.65M
95.34%-829.19K
-6.54%-5.84M
600.13%11.97M
23.80%-3.4M
34.75%-3.57M
17.45%-17.8M
-5.48M
-2.39M
Net non-operating interest income expense
446.50%167.31K
293.38%142K
-24.35%166.5K
230.63%87.05K
-75.78%12.74K
-44.05%30.62K
-58.24%36.1K
-31.89%220.1K
26.33K
52.62K
Non-operating interest income
446.50%167.31K
293.38%142K
-24.35%166.5K
230.63%87.05K
-75.78%12.74K
-44.05%30.62K
-58.24%36.1K
-31.89%220.1K
--26.33K
--52.62K
Other net income (expense)
179.30%4.01M
-270.76%-4.43M
-108.78%-175.31K
-224.58%-3.4M
-91.08%-803.73K
872.37%1.43M
2,156.10%2.59M
803.93%2M
2.73M
-420.62K
Gain on sale of security
265.44%5.24M
77.95%-61.74K
-108.78%-175.31K
-224.58%-3.4M
-91.08%-803.73K
872.37%1.43M
-121.91%-280.04K
803.93%2M
--2.73M
---420.62K
Special income (charges)
---1.24M
----
----
----
----
--0
----
----
----
----
-Less:Restructuring and merger&acquisition
--1.24M
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
----
-251.98%-4.37M
----
----
----
----
--2.87M
----
----
----
Income before tax
194.70%1.83M
-961.00%-9.94M
94.62%-838K
-236.27%-9.15M
504.85%11.18M
57.91%-1.93M
82.99%-936.97K
27.61%-15.58M
-2.72M
-2.76M
Income tax
-399.72%-34.79K
73.68%-34.79K
-436.38%-468.37K
-681.46%-266.6K
-595.55%-81.19K
133.36%11.61K
-279.92%-132.19K
37.26%-87.32K
-34.12K
16.38K
Net income
195.92%1.86M
-1,130.95%-9.91M
97.61%-369.63K
-230.61%-8.88M
505.38%11.26M
57.33%-1.94M
85.29%-804.79K
27.54%-15.49M
-2.69M
-2.78M
Net income continuous Operations
195.92%1.86M
-1,130.95%-9.91M
97.61%-369.63K
-230.61%-8.88M
505.38%11.26M
57.33%-1.94M
85.29%-804.79K
27.54%-15.49M
---2.69M
---2.78M
Minority interest income
Net income attributable to the parent company
195.92%1.86M
-1,130.95%-9.91M
97.61%-369.63K
-230.61%-8.88M
505.38%11.26M
57.33%-1.94M
85.29%-804.79K
27.54%-15.49M
-2.69M
-2.78M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
195.92%1.86M
-1,130.95%-9.91M
97.61%-369.63K
-230.61%-8.88M
505.38%11.26M
57.33%-1.94M
85.29%-804.79K
27.54%-15.49M
-2.69M
-2.78M
Basic earnings per share
133.33%0.41
-611.29%-4.41
98.76%-0.23
-69.30%-5.79
331.45%6.55
76.84%-1.23
-1,312.37%-0.62
-7,658.33%-18.62
-3.42
-2.83
Diluted earnings per share
56.98%-0.77
-611.29%-4.41
98.76%-0.23
-69.30%-5.79
331.45%6.55
66.29%-1.79
-1,312.37%-0.62
-7,658.33%-18.62
-3.42
-2.83
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Dec 31, 2025(Q1)Sep 30, 2025(FY)Jun 30, 2025(Q4)Jun 30, 2025(Q3)Mar 31, 2025(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024
Total revenue 0015.65M-13.27K15M662.72K0000
Operating revenue --0--0--15.65M---13.27K--15M--662.72K--0--0--0--0
Cost of revenue
Gross profit
Operating expense -42.22%2.35M58.44%5.65M-7.41%16.48M6.30%5.82M26.50%3.03M-8.93%4.06M-34.75%3.57M-17.45%17.8M5.48M2.39M
Selling and administrative expenses -19.10%2.13M12.01%1.87M-8.27%7.77M-13.06%2.07M17.68%1.41M4.42%2.63M-29.95%1.67M-4.90%8.47M--2.38M--1.2M
-General and administrative expense -19.10%2.13M12.01%1.87M-8.27%7.77M-13.06%2.07M17.68%1.41M4.42%2.63M-29.95%1.67M-4.90%8.47M--2.38M--1.2M
Research and development costs -59.83%697.72K99.15%3.79M-4.38%9.01M21.16%3.75M34.83%1.62M-14.64%1.74M-38.45%1.9M-27.95%9.42M--3.1M--1.2M
Other operating expenses -56.40%-478.96K-----214.98%-299.91K570.51%1.1K2,028.78%5.23K-223.34%-306.23K----77.48%-95.22K---234---271
Operating profit 30.95%-2.35M-58.44%-5.65M95.34%-829.19K-6.54%-5.84M600.13%11.97M23.80%-3.4M34.75%-3.57M17.45%-17.8M-5.48M-2.39M
Net non-operating interest income expense 446.50%167.31K293.38%142K-24.35%166.5K230.63%87.05K-75.78%12.74K-44.05%30.62K-58.24%36.1K-31.89%220.1K26.33K52.62K
Non-operating interest income 446.50%167.31K293.38%142K-24.35%166.5K230.63%87.05K-75.78%12.74K-44.05%30.62K-58.24%36.1K-31.89%220.1K--26.33K--52.62K
Other net income (expense) 179.30%4.01M-270.76%-4.43M-108.78%-175.31K-224.58%-3.4M-91.08%-803.73K872.37%1.43M2,156.10%2.59M803.93%2M2.73M-420.62K
Gain on sale of security 265.44%5.24M77.95%-61.74K-108.78%-175.31K-224.58%-3.4M-91.08%-803.73K872.37%1.43M-121.91%-280.04K803.93%2M--2.73M---420.62K
Special income (charges) ---1.24M------------------0----------------
-Less:Restructuring and merger&acquisition --1.24M------------------0----------------
Other non- operating income (expenses) -----251.98%-4.37M------------------2.87M------------
Income before tax 194.70%1.83M-961.00%-9.94M94.62%-838K-236.27%-9.15M504.85%11.18M57.91%-1.93M82.99%-936.97K27.61%-15.58M-2.72M-2.76M
Income tax -399.72%-34.79K73.68%-34.79K-436.38%-468.37K-681.46%-266.6K-595.55%-81.19K133.36%11.61K-279.92%-132.19K37.26%-87.32K-34.12K16.38K
Net income 195.92%1.86M-1,130.95%-9.91M97.61%-369.63K-230.61%-8.88M505.38%11.26M57.33%-1.94M85.29%-804.79K27.54%-15.49M-2.69M-2.78M
Net income continuous Operations 195.92%1.86M-1,130.95%-9.91M97.61%-369.63K-230.61%-8.88M505.38%11.26M57.33%-1.94M85.29%-804.79K27.54%-15.49M---2.69M---2.78M
Minority interest income
Net income attributable to the parent company 195.92%1.86M-1,130.95%-9.91M97.61%-369.63K-230.61%-8.88M505.38%11.26M57.33%-1.94M85.29%-804.79K27.54%-15.49M-2.69M-2.78M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 195.92%1.86M-1,130.95%-9.91M97.61%-369.63K-230.61%-8.88M505.38%11.26M57.33%-1.94M85.29%-804.79K27.54%-15.49M-2.69M-2.78M
Basic earnings per share 133.33%0.41-611.29%-4.4198.76%-0.23-69.30%-5.79331.45%6.5576.84%-1.23-1,312.37%-0.62-7,658.33%-18.62-3.42-2.83
Diluted earnings per share 56.98%-0.77-611.29%-4.4198.76%-0.23-69.30%-5.79331.45%6.5566.29%-1.79-1,312.37%-0.62-7,658.33%-18.62-3.42-2.83
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and Show More